• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺导管腺癌中物理和免疫肿瘤微环境的关系。

Relationships between physical and immunological tumor microenvironment in pancreatic ductal adenocarcinoma.

机构信息

Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital East, Kashiwa, Japan.

Course of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo, Japan.

出版信息

Cancer Sci. 2023 Sep;114(9):3783-3792. doi: 10.1111/cas.15853. Epub 2023 Jun 19.

DOI:10.1111/cas.15853
PMID:37337413
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10475771/
Abstract

Pancreatic ductal adenocarcinoma (PDAC) is physically palpated as a hard tumor with an unfavorable prognosis. Assessing physical features and their association with pathological features could help to elucidate the mechanism of physical abnormalities in cancer tissues. A total of 93 patients who underwent radical surgery for pancreatic and bile duct cancers at a single center hospital during a 28-month period were recruited for this study that aimed to estimate the stiffness of PDAC tissues compared to the other neoplasms and assess relationships between tumor stiffness and pathological features. Physical alterations and pathological features of PDAC, with or without preoperative therapy, were analyzed. The immunological tumor microenvironment was evaluated using multiplexed fluorescent immunohistochemistry. The stiffness of PDAC correlated with the ratio of Azan-Mallory staining, α-smooth muscle actin, and collagen I-positive areas of the tumors. Densities of CD8 T cells and CD204 macrophages were associated with tumor stiffness in cases without preoperative therapy. Pancreatic ductal adenocarcinoma treated with preoperative therapy was softer than that without, and the association between tumor stiffness and immune cell infiltration was not shown after preoperative therapy. We observed the relationship between tumor stiffness and immunological features in human PDAC for the first time. Immune cell densities in the tumor center were smaller in hard tumors than in soft tumors without preoperative therapies. Preoperative therapy could alter physical and immunological aspects, warranting further study. Understanding of the correlations between physical and immunological aspects could lead to the development of new therapies.

摘要

胰腺导管腺癌(PDAC)在临床上表现为质地坚硬的肿瘤,预后不良。评估其质地特征及其与病理特征的相关性,有助于阐明癌症组织质地异常的机制。本研究共纳入了 93 例在单中心医院接受胰腺和胆管癌根治性手术的患者,旨在评估 PDAC 组织与其他肿瘤相比的硬度,并评估肿瘤硬度与病理特征之间的关系。分析了 PDAC 的质地改变和病理特征,包括术前治疗和无术前治疗的情况。使用多重荧光免疫组化评估肿瘤的免疫微环境。PDAC 的硬度与 Azan-Mallory 染色、α-平滑肌肌动蛋白和胶原 I 阳性肿瘤区域的比例相关。在无术前治疗的情况下,CD8 T 细胞和 CD204 巨噬细胞的密度与肿瘤硬度相关。接受术前治疗的 PDAC 比未接受治疗的更软,且术前治疗后,肿瘤硬度与免疫细胞浸润之间的关联不再明显。我们首次观察到人类 PDAC 中肿瘤硬度与免疫特征之间的关系。在无术前治疗的情况下,硬肿瘤的肿瘤中心免疫细胞密度小于软肿瘤。术前治疗可能会改变肿瘤的质地和免疫方面,需要进一步研究。了解物理和免疫方面的相关性可能会导致新疗法的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5905/10475771/27cea2860bf5/CAS-114-3783-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5905/10475771/4a88bf27673a/CAS-114-3783-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5905/10475771/a6429d75d431/CAS-114-3783-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5905/10475771/da6ad40693b7/CAS-114-3783-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5905/10475771/1728c2dde89c/CAS-114-3783-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5905/10475771/ccb14f9316fd/CAS-114-3783-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5905/10475771/27cea2860bf5/CAS-114-3783-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5905/10475771/4a88bf27673a/CAS-114-3783-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5905/10475771/a6429d75d431/CAS-114-3783-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5905/10475771/da6ad40693b7/CAS-114-3783-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5905/10475771/1728c2dde89c/CAS-114-3783-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5905/10475771/ccb14f9316fd/CAS-114-3783-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5905/10475771/27cea2860bf5/CAS-114-3783-g006.jpg

相似文献

1
Relationships between physical and immunological tumor microenvironment in pancreatic ductal adenocarcinoma.胰腺导管腺癌中物理和免疫肿瘤微环境的关系。
Cancer Sci. 2023 Sep;114(9):3783-3792. doi: 10.1111/cas.15853. Epub 2023 Jun 19.
2
Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator in Pancreatic Ductal Adenocarcinoma.在胰腺导管腺癌中,CD8 + T淋巴细胞的上皮内攻击而非肿瘤内浸润是一个良好的预后指标。
Curr Mol Med. 2017;17(10):689-698. doi: 10.2174/1566524018666180308115705.
3
The immunological impact of preoperative chemoradiotherapy on the tumor microenvironment of pancreatic cancer.术前放化疗对胰腺癌肿瘤微环境的免疫影响。
Cancer Sci. 2021 Jul;112(7):2895-2904. doi: 10.1111/cas.14914. Epub 2021 May 19.
4
Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma.活化的胰腺星状细胞将 CD8+T 细胞隔离,以减少其浸润胰腺导管腺癌的瘤周区域。
Gastroenterology. 2013 Nov;145(5):1121-32. doi: 10.1053/j.gastro.2013.07.025. Epub 2013 Jul 25.
5
PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8 tumor-infiltrating lymphocytes: highly sensitive detection using phosphor-integrated dot staining.在CD8肿瘤浸润淋巴细胞高的胰腺癌患者中,程序性死亡受体配体1(PD-L1)表达是一个不良预后因素:使用磷整合点染色进行高灵敏度检测。
Int J Clin Oncol. 2017 Aug;22(4):726-733. doi: 10.1007/s10147-017-1112-3. Epub 2017 Mar 18.
6
Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry.单细胞质谱流式细胞术揭示的人胰腺导管腺癌的局部和全身免疫特征。
J Immunother Cancer. 2022 Jul;10(7). doi: 10.1136/jitc-2022-004638.
7
[Pathological features related to onco-immunity and their clinical significance of pancreatic ductal adenocarcinoma].[胰腺导管腺癌的肿瘤免疫相关病理特征及其临床意义]
Zhonghua Bing Li Xue Za Zhi. 2022 May 8;51(5):419-424. doi: 10.3760/cma.j.cn112151-20210902-00641.
8
Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in Pancreatic Ductal Adenocarcinoma: A Retrospective Analysis.肌肉减少症与胰腺导管腺癌不良预后和肿瘤浸润 CD8 阳性 T 细胞减少相关:一项回顾性分析。
Ann Surg Oncol. 2023 Sep;30(9):5776-5787. doi: 10.1245/s10434-023-13569-2. Epub 2023 May 16.
9
C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer.C4b 结合蛋白 α 链通过促进肿瘤浸润淋巴细胞在胰腺癌肿瘤微环境中的积累增强抗肿瘤免疫。
J Exp Clin Cancer Res. 2021 Jun 24;40(1):212. doi: 10.1186/s13046-021-02019-0.
10
Neuromedin U regulates the anti-tumor activity of CD8 T cells and glycolysis of tumor cells in the tumor microenvironment of pancreatic ductal adenocarcinoma in an NMUR1-dependent manner.神经调节素 U 通过 NMUR1 依赖的方式调节胰腺导管腺癌肿瘤微环境中 CD8 T 细胞的抗肿瘤活性和肿瘤细胞的糖酵解。
Cancer Sci. 2024 Feb;115(2):334-346. doi: 10.1111/cas.16024. Epub 2023 Dec 10.

本文引用的文献

1
Histological tumor necrosis in pancreatic cancer after neoadjuvant therapy.新辅助治疗后胰腺癌的组织学肿瘤坏死。
Oncol Rep. 2022 Jul;48(1). doi: 10.3892/or.2022.8332. Epub 2022 May 18.
2
The Immune Landscape of Human Pancreatic Ductal Carcinoma: Key Players, Clinical Implications, and Challenges.人类胰腺导管腺癌的免疫格局:关键因素、临床意义及挑战
Cancers (Basel). 2022 Feb 16;14(4):995. doi: 10.3390/cancers14040995.
3
Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits.靶向胰腺癌中的肿瘤-基质相互作用:胶原蛋白和机械特性的影响
Front Cell Dev Biol. 2021 Nov 25;9:787485. doi: 10.3389/fcell.2021.787485. eCollection 2021.
4
Targeting the Stroma in the Management of Pancreatic Cancer.胰腺癌治疗中针对基质的研究
Front Oncol. 2021 Jul 14;11:691185. doi: 10.3389/fonc.2021.691185. eCollection 2021.
5
Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses.肉瘤样肝细胞癌有别于普通肝细胞癌:临床病理、转录组学和免疫分析。
Int J Cancer. 2021 Aug 1;149(3):546-560. doi: 10.1002/ijc.33545. Epub 2021 Mar 13.
6
Physical traits of cancer.癌症的物理特征。
Science. 2020 Oct 30;370(6516). doi: 10.1126/science.aaz0868.
7
Objective assessment of tumor regression in post-neoadjuvant therapy resections for pancreatic ductal adenocarcinoma: comparison of multiple tumor regression grading systems.新辅助治疗后胰腺导管腺癌切除标本中肿瘤退缩的客观评估:多种肿瘤退缩分级系统的比较。
Sci Rep. 2020 Oct 26;10(1):18278. doi: 10.1038/s41598-020-74067-z.
8
The Immune Microenvironment in Pancreatic Cancer.胰腺癌中的免疫微环境。
Int J Mol Sci. 2020 Oct 3;21(19):7307. doi: 10.3390/ijms21197307.
9
Area of residual tumor (ART) can predict prognosis after post neoadjuvant therapy resection for pancreatic ductal adenocarcinoma.残余肿瘤(ART)面积可预测新辅助治疗后胰腺导管腺癌切除术后的预后。
Sci Rep. 2019 Nov 20;9(1):17145. doi: 10.1038/s41598-019-53801-2.
10
Characterization of spatial distribution of tumor-infiltrating CD8 T cells refines their prognostic utility for pancreatic cancer survival.肿瘤浸润 CD8 T 细胞的空间分布特征可改善其对胰腺癌生存预后的预测价值。
Mod Pathol. 2019 Oct;32(10):1495-1507. doi: 10.1038/s41379-019-0291-z. Epub 2019 Jun 11.